According to this model, the inhibition of angiogenesis observed in Plexin-B2-depleted GBM xenografts in mice may be due to reduced tumor cell perivascular spread associated with the disruption of the Sema4C/Plexin-B2-mediated pro-migratory pathway [44]. This evidence concerns the gene SEMA4C and glioblastoma.